Literature DB >> 25962759

Generation and propagation of recombinant mumps viruses exhibiting an additional U residue in the homopolymeric U tract of the F gene-end signal.

Christian J Sauder1, Laurie Ngo, Vahan Simonyan, Yu Cong, Cheryl Zhang, Malen Link, Tahir Malik, Steven A Rubin.   

Abstract

As a member of the family paramyxoviridae, subfamily paramyxovirinae, the genome of mumps virus (MuV) is postulated to be polyhexameric in length in order to be able to replicate efficiently. While all natural MuV strains sequenced so far obey to this "rule of six," we describe here the isolation of recombinant MuVs that appeared to contain an additional U residue in the homopolymeric tract of the F gene-end signal, resulting in a genome length of 6n + 1. Sequencing of several plaque-purified viruses from these preparations did not reveal the existence of length-correcting mutations, suggesting that they are violators of the rule of six. Employing high-throughput sequencing technology, we provide evidence that the insertion of an additional U residue is mainly the result of the rescue system used that relies on T7 RNA polymerase. Limited in vitro and in vivo testing of the viruses did not reveal any significant impact of the longer genome on virus replication or virulence, suggesting that the rule of six is not a strict requirement for MuV replication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25962759     DOI: 10.1007/s11262-015-1204-y

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  26 in total

1.  Spacing constraints on reinitiation of paramyxovirus transcription: the gene end U tract acts as a spacer to separate gene end from gene start sites.

Authors:  J C Rassa; G M Wilson; G A Brewer; G D Parks
Journal:  Virology       Date:  2000-09-01       Impact factor: 3.616

2.  Mumps vaccines: do we need a new one?

Authors:  Steven Rubin; Judy Beeler
Journal:  Pediatr Infect Dis J       Date:  2013-10       Impact factor: 2.129

3.  Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.

Authors:  Christian J Sauder; Cheryl X Zhang; Malen A Link; W Paul Duprex; Kathryn M Carbone; Steven A Rubin
Journal:  Vaccine       Date:  2009-08-04       Impact factor: 3.641

4.  Commentary: Mumps vaccines: do we need a new one?

Authors:  Stanley A Plotkin
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

5.  Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5.

Authors:  S K Murphy; G D Parks
Journal:  Virology       Date:  1997-05-26       Impact factor: 3.616

6.  Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

Authors:  Valentina A Volchkova; Olga Dolnik; Miguel J Martinez; Olivier Reynard; Viktor E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

7.  The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA.

Authors:  P Calain; L Roux
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence.

Authors:  Tahir Malik; Candie Wolbert Shegogue; Kellie Werner; Laurie Ngo; Christian Sauder; Cheryl Zhang; William Paul Duprex; Steven Rubin
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

9.  The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.

Authors:  Ken Lemon; Bertus K Rima; Stephen McQuaid; Ingrid V Allen; W Paul Duprex
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  HIVE-hexagon: high-performance, parallelized sequence alignment for next-generation sequencing data analysis.

Authors:  Luis Santana-Quintero; Hayley Dingerdissen; Jean Thierry-Mieg; Raja Mazumder; Vahan Simonyan
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

View more
  1 in total

Review 1.  Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research.

Authors:  Marc Kusinitz; Emily Braunstein; Carolyn A Wilson
Journal:  Front Med (Lausanne)       Date:  2017-06-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.